-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our 12-month target by $15 to $365, valuing EG shares at 7x our 2026 operating EPS estimate of $53.16 (cut today by $0.99) and at 6x our 2027 EPs estimate of $60.65, versus the one-year average forward multiple of 6x and a peer average of 8.6x. We acknowledge EG's discounted valuation to peers, reflecting its restructuring. To that end, we expect revenues in 2026 to be flat to down 5%. Q1 operating EPS of $16.08 versus $6.45 a year ago topped our $15.27 estimate and the $13.96 consensus view. Operating revenues declined 4.4% on a 7.2% drop in earned premiums and 15% rise in investment income, while the combined ratio improved dramatically to 91.2% from 102.7%. We applaud EG's restructuring, including the sale of renewal rights to its retail commercial insurance business to focus on its core reinsurance operations. EG expects pre-tax charges of $250M-$350M over 2025-2026. We are concerned becoming a pure-play reinsurer may not expand valuation multiples given EG's mixed underwriting track record.